Circulating Tumor DNA To Assess Minimal Residual Disease: Versatile, but How Valuable? Brown JR, Sonpavde GP, Calaway A, Barata PC, et al. Eur Urol 2024;86:312-314.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Brown JR, Sonpavde GP, Calaway A, Barata PC, et al. Circulating Tumor DNA To Assess Minimal Residual Disease: Versatile, but How Valuable? Eur Urol 2024;86:312-314.
PMID: 38880696